Victory Capital Management Inc Bio Techne Corp Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

A detailed history of Victory Capital Management Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Victory Capital Management Inc holds 42,594 shares of TECH stock, worth $3.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,594
Previous 45,616 6.62%
Holding current value
$3.21 Million
Previous $3.27 Million 4.13%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$70.96 - $82.35 $214,441 - $248,861
-3,022 Reduced 6.62%
42,594 $3.4 Million
Q2 2024

Aug 05, 2024
SELL
$62.12 - $84.15 $84,669 - $114,696
-1,363 Reduced 2.9%
45,616 $3.27 Million
Q1 2024

May 03, 2024
SELL
$65.98 - $77.09 $129,122 - $150,865
-1,957 Reduced 4.0%
46,979 $3.31 Million
Q4 2023

Feb 05, 2024
BUY
$52.83 - $78.22 $928,540 - $1.37 Million
17,576 Added 56.05%
48,936 $3.78 Million
Q3 2023

Nov 06, 2023
SELL
$67.52 - $89.42 $525,508 - $695,955
-7,783 Reduced 19.88%
31,360 $2.13 Million
Q2 2023

Jul 27, 2023
BUY
$73.76 - $85.98 $88,880 - $103,605
1,205 Added 3.18%
39,143 $3.2 Million
Q1 2023

May 02, 2023
SELL
$71.62 - $86.62 $2.94 Million - $3.56 Million
-41,052 Reduced 51.97%
37,938 $2.81 Million
Q4 2022

Feb 10, 2023
BUY
$80.67 - $352.29 $977,478 - $4.27 Million
12,117 Added 18.12%
78,990 $6.55 Million
Q4 2022

Feb 09, 2023
BUY
$80.67 - $352.29 $3.74 Million - $16.3 Million
46,394 Added 226.54%
66,873 $5.54 Million
Q3 2022

Nov 02, 2022
SELL
$282.54 - $391.85 $838,296 - $1.16 Million
-2,967 Reduced 12.65%
20,479 $5.82 Million
Q2 2022

Aug 01, 2022
BUY
$322.67 - $449.65 $670,508 - $934,372
2,078 Added 9.72%
23,446 $8.13 Million
Q1 2022

May 04, 2022
SELL
$353.85 - $487.79 $1.09 Million - $1.5 Million
-3,082 Reduced 12.61%
21,368 $8.11 Million
Q4 2021

Feb 07, 2022
SELL
$456.15 - $525.06 $114,493 - $131,790
-251 Reduced 1.02%
24,450 $12.6 Million
Q3 2021

Nov 02, 2021
SELL
$444.87 - $538.88 $1.38 Million - $1.67 Million
-3,100 Reduced 11.15%
24,701 $12 Million
Q2 2021

Aug 03, 2021
BUY
$387.35 - $450.26 $252,552 - $293,569
652 Added 2.4%
27,801 $12.5 Million
Q1 2021

May 04, 2021
BUY
$314.62 - $411.0 $1.16 Million - $1.52 Million
3,694 Added 15.75%
27,149 $10.4 Million
Q4 2020

Feb 01, 2021
BUY
$246.9 - $321.87 $45,676 - $59,545
185 Added 0.8%
23,455 $7.45 Million
Q3 2020

Nov 09, 2020
BUY
$232.22 - $282.96 $334,629 - $407,745
1,441 Added 6.6%
23,270 $5.77 Million
Q2 2020

Aug 07, 2020
BUY
$185.43 - $279.56 $343,787 - $518,304
1,854 Added 9.28%
21,829 $5.76 Million
Q1 2020

May 04, 2020
SELL
$161.17 - $221.51 $836,149 - $1.15 Million
-5,188 Reduced 20.62%
19,975 $3.79 Million
Q4 2019

Feb 06, 2020
BUY
$189.68 - $222.09 $50,454 - $59,075
266 Added 1.07%
25,163 $5.52 Million
Q4 2019

Feb 04, 2020
BUY
$189.68 - $222.09 $352,046 - $412,199
1,856 Added 8.06%
24,897 $5.23 Million
Q3 2019

Nov 12, 2019
BUY
$183.56 - $216.72 $1.62 Million - $1.91 Million
8,803 Added 61.83%
23,041 $4.51 Million
Q2 2019

Aug 15, 2019
SELL
$188.72 - $215.43 $158,902 - $181,392
-842 Reduced 5.58%
14,238 $2.97 Million
Q1 2019

May 03, 2019
SELL
$136.09 - $200.44 $651,054 - $958,904
-4,784 Reduced 24.08%
15,080 $2.99 Million
Q4 2018

Feb 05, 2019
SELL
$132.75 - $203.8 $9,690 - $14,877
-73 Reduced 0.37%
19,864 $2.88 Million
Q3 2018

Nov 01, 2018
SELL
$147.44 - $204.11 $1.18 Million - $1.63 Million
-7,980 Reduced 28.58%
19,937 $4.07 Million
Q2 2018

Aug 02, 2018
BUY
$144.9 - $165.58 $475,561 - $543,433
3,282 Added 13.32%
27,917 $4.13 Million
Q1 2018

May 04, 2018
BUY
$131.46 - $151.04 $3.24 Million - $3.72 Million
24,635 New
24,635 $3.72 Million

Others Institutions Holding TECH

# of Institutions
603
Shares Held
151M
Call Options Held
195K
Put Options Held
53.2K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.95B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email